与多药耐药相关的细胞信号通路新药物
被引量：2
Some new signaling-oriented drugs related to MDR
摘要
多药耐药的原因之一是肿瘤细胞对药物引起的细胞凋亡有耐受。药物逆转这种耐受的一个靶位是细胞信号传导通路。现简述与细胞凋亡及存活相关的信号传导通路及几种以这些通路为靶位的药物。
出处
《国外医学（肿瘤学分册）》
2005年第3期190-193,共4页
Foreign Medical Sciences (Cancer Section)
基金
山东省卫生厅资助项目(2001CA2CAA2)
参考文献18
-
1Kasimir Bauer S, Beelen D,Flasshove M,et al. Impact of the expression of P glycoprotein, the multidrug resistance- related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia. Exp Hematol,2002,30( 11 ): 1302-1308.
-
2Tsuruo T. Molecular cancer therapeutics: recent progress and targets in drug resistance. Intern Med,2003,42 (3) :237-243.
-
3Chinnaiyan AM. The apoptosome: heart and soul of the cell death machine. Neoplasia,1999,1 (1) :5-15.
-
4Dijkers PF,Medema RH,Lammers JW,et al. Expression of the proapoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR- L1. Curr Biol, 2000,10 (19): 1201 - 1204.
-
5Taylor ST, Hickman JA, Dive C. Epigenetic determinants of resistance to etoposide regulation of Bcl- x (L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst,2000, 92 (1): 18-23.
-
6English J,Pearson G,Wilsbacher J, et al. New insights into the control of MAP kinase pathways. Exp Cell Res, 1999, 253 (1): 255-270.
-
7Vanhaesebroeck B, Alessi DR. The PI3K-PDKI connection: more than just a road to PKB. Bioche J,2000, 346(pt3) :561-576.
-
8Knuefermann C, Lu Y, Liu B, et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.Oncogene,2003,22(21 ) :3205-3212.
-
9Favata MF, Horiuchi KY, Manos E J, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem,1998,273 (29): 18623-18632.
-
10Sebolt Leopold JS,Dudley DT, Herrera R,et al. Blockade of the MAP kinase pathway suppresses growth of colon tumours in vivo.Nat Med,1999, 5(7) :810-816.
同被引文献26
-
1苗旭东,杨迪生,叶招明,徐荣臻,张桂娣.细菌氧化还原蛋白azurin诱导U2OS细胞凋亡过程中caspase-3的活化[J].中国病理生理杂志,2004,20(9):1650-1653. 被引量：7
-
2李江涛,彭淑牖,刘颖斌,王新保,王海军,王建伟,许斌,李海军,冯雪冬,钱浩然,吴育连,方河清.糖基化神经酰胺合成酶及相关基因的表达与人胆囊癌多药耐药[J].中华普通外科杂志,2005,20(6):382-383. 被引量：9
-
3郜永顺,陈孝平.肝细胞癌多药耐药机制及其逆转策略研究进展[J].中华实验外科杂志,2006,23(4):639-640. 被引量：7
-
4李江涛,彭淑牖,王新保,刘颖斌,王建伟,许斌,李海军,冯雪冬,钱浩然,王海军,吴育连,方河清.阿霉素诱导人胆囊癌细胞耐药过程中糖基化神经酰胺合成酶及caspase 3的动态变化[J].中国病理生理杂志,2006,22(4):752-756. 被引量：2
-
5陆震,熊茂明,孟翔凌.多药耐药基因相关蛋白在原发性肝癌中的表达及意义[J].中国临床保健杂志,2006,9(6):556-559. 被引量：3
-
6包炎明 汤钊猷 马曾辰 等.人肝癌在裸大鼠皮下、腹腔和肝内移植的比较[J].中华肿瘤杂志,1989,5(11):329-329.
-
7Irene OL. Ng,Liu CL, Fan ST,et al. Expression of P-glycoprotein in human hepatocellular carcinoma a deteminant of chemotherapy response[ J ]. Am J Clin Pathol,2000,113 (3) :355-363.
-
8Kohyama-koganaya A, Hirabayashi Y. Role of glucosylce ramide. synthase as negative regulator for ceramide [ J]. Tanpakushitsu Kakusan Koso,2002,47 (4 Suppl) :470-475.
-
9Sietsma H, Veldman R J, Kok JW, et el. The invelvement of sphingolipids in multidrug resistance[ J]. Jmembr Biol,2001,181 ( 3 ) : 153- 162.
-
10Liu YY, Han TY, GiulianoAE, et al. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells[ J]. J Biol Chem, 1999, 274(2) :1140- 1146.
-
1王绍奎,张维浩,孙兰萍,孙翔宇,赵炎,左文述.乳腺癌组织中多药耐药相关蛋白的表达及其临床意义[J].中华肿瘤防治杂志,2007,14(9):692-694. 被引量：5
-
2张明辉,张清媛,赵曙,马文杰,许家玲.吉西他滨联合洛铂治疗蒽环类及紫杉类耐药转移性乳腺癌的临床观察[J].中华肿瘤防治杂志,2010,17(19):1565-1567. 被引量：16
-
3卢列盛,宋科瑛,李克.肿瘤多药耐药和侵袭转移关系的研究[J].国际肿瘤学杂志,2006,33(9):665-667. 被引量：2
-
4赵瑜,薄剑,李红华,王全顺,吴晓雄,靖玉,于力.lrp和mrp基因在预测急性非淋巴细胞白血病耐药的意义[J].医学临床研究,2005,22(9):1193-1195. 被引量：2
-
5章忠明,谭达人,谢兆霞,黄程辉.急性白血病患者肺耐药相关蛋白检测及临床意义[J].临床血液学杂志,2005,18(6):363-364.
-
6高波,李海平,陶建蜀,张吉才,余宗涛,李莉.宫颈癌中耐药基因的表达及其临床意义[J].国际检验医学杂志,2011,32(18):2049-2050. 被引量：1
-
7余宗涛,高琼,高波,吕军,张吉才.非小细胞肺癌中肺耐药蛋白的表达及与临床病理特征的关系[J].国际检验医学杂志,2012,33(9):1042-1044. 被引量：6
-
8盛雅萍,郭伟剑.5-氟尿嘧啶耐药机制及其治疗[J].国际肿瘤学杂志,2006,33(7):502-505. 被引量：10
-
9刘春辉（综述）,陈明（审校）.前列腺癌肿瘤干细胞与多药耐药研究进展[J].国际泌尿系统杂志,2012,32(2):215-218.
-
10王开雷,李乐平,靖昌庆.大肠癌多药耐药逆转的研究进展[J].中国现代普通外科进展,2010,13(4):306-310. 被引量：7
